Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
12 studies found for:    Open Studies | "Epistaxis"
Show Display Options
Rank Status Study
1 Recruiting Management of Persistent Epistaxis Using Floseal Hemostatic Matrix
Condition: Epistaxis
Interventions: Device: Floseal Hemostatic Matrix;   Procedure: Traditional Nasal Packing
2 Recruiting Topical Intranasal Tranexamic Acid for Epistaxis in the Emergency Department
Condition: Epistaxis
Interventions: Drug: Tranexamic Acid;   Drug: 0.9% Sodium Chloride
3 Not yet recruiting Correlation Between Epistaxis and Cardiovascular Disease
Conditions: Cardiovascular Disease;   Epistaxis
Intervention: Biological: Blood-pressure variability
4 Recruiting Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT)
Conditions: Hereditary Hemorrhagic Telangiectasia (HHT);   Epistaxis
Interventions: Drug: Floseal;   Other: Packing
5 Recruiting , "Mucosal Injury During Nasotracheal Intubation for Dental Procedures in Children-does the Tube Design Matter?"
Condition: Epistaxis
Interventions: Device: Parker flex-tip nasotracheal tube;   Device: Standard nasotracheal tube
6 Not yet recruiting Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT
Conditions: Hereditary Hemorrhagic Telangiectasia;   Epistaxis
Interventions: Drug: Mupirocin;   Other: Placebo
7 Recruiting Intranasal Bevacizumab for HHT-Related Epistaxis
Conditions: HHT;   Hereditary Hemorrhagic Telangiectasia;   Epistaxis;   Nose Bleeds;   Nasal Bleeding
Interventions: Drug: Bevacizumab;   Drug: Placebo (Saline)
8 Recruiting The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial.
Conditions: Epistaxis;   Blood Pressure
Interventions: Drug: Oxymetazoline 0.05%;   Drug: Phenylephrine 0.25%;   Drug: Lidocaine 1% plus epinephrine 1:100,000;   Drug: Bacteriostatic 0.9% NaCL
9 Recruiting Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO)
Condition: Hemorrhagic Hereditary Telangiectasia (HHT)
Interventions: Drug: Timolol nasal spray;   Drug: Placebo nasal spray
10 Recruiting Risk and Importance of Peroperative Nasal Hemorrhage in the Treatment of Lacrimal Duct Obstruction in Young Children
Condition: Lacrimal Duct Obstruction
Intervention: Procedure: "pushed" mono-canaliculonasal intubation
11 Recruiting Iron Deficiency and Hereditary Haemorrhagic Telangiectasia
Condition: Hereditary Haemorrhagic Telangiectasia
Intervention: Drug: Ferrous sulphate 200mg oral tablet
12 Recruiting Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose
Condition: Telangiectasia, Hereditary Hemorrhagic
Intervention: Drug: bevacuzimab spray

Study has passed its completion date and status has not been verified in more than two years.